Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.

Sylvain Cardinaud 1 Romain Bouziat 1 Pierre-Simon Rohrlich 1, 2 Sophie Tourdot 1 Laurence Weiss 3 Pierre Langlade-Demoyen 1 Anne Burgevin 4 Susana Fiorentino 4 Peter Van Endert 4 François Lemonnier 1
1 Immunité Cellulaire Antivirale
2 HOTE GREFFON - Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098)
3 HEGP - Hôpital Européen Georges Pompidou [APHP]
4 Diabète de Type 1 : mécanismes et traitements immunologiques
Abstract : OBJECTIVE: To design a vaccine construct containing various but conserved HIV-1-derived epitopes and generating broad CD8 T cell responses. METHODS: HLA-B7 transgenic H-2KD KO transgenic mice were used to identify potential new HLA-B07.02-restricted HIV-1-derived epitopes. Immunological recognition of these epitopes was confirmed by IFN-gamma ELISpot assays with PBMCs from HLA-B*0702 HIV-1-infected individuals. For these peptides as well as others previously identified, the capacity to induce cross-reactive responses against their frequent allelic variants was evaluated in the mouse model. A set of epitopes inducing strong T cell responses against various and conserved regions of HIV-1 was selected. A DNA vaccine was designed to express them as a unique antigen with or without a three amino acid ARY extension flanking each epitope. The spectrum of CD8 T responses generated by polyepitope constructs was tested in HLA-B7 transgenic mice. RESULTS: Five new epitopes were identified in accessory and regulatory HIV-1 proteins. Twelve HLA-B07.02-restricted epitopes were selected on the basis of their structural conservation and cross-reactive immunogenicity. The ARY N-terminal extension flanking each epitope markedly increases their affinity for TAP and the use of this flanking extension in polyepitope vaccine has a sizable advantage to induce CD8 T cell cytotoxic responses in mice following DNA immunization. CONCLUSION: The HLA-B7 mouse model allows to rapidly identify various HIV-1-derived epitopes of vaccine interest. Grouped in a polyepitope construct designed to increase their processing, this vaccine may be suitable for inducing multiple and relevant HIV-1-specific CTL responses in humans.
Type de document :
Article dans une revue
AIDS, Lippincott, Williams & Wilkins, 2009, 23 (15), pp.1945-54. 〈10.1097/QAD.0b013e32832fae88〉
Liste complète des métadonnées
http://www.hal.inserm.fr/inserm-00484766
Contributeur : Philippe Saas <>
Soumis le : mercredi 19 mai 2010 - 09:54:44
Dernière modification le : lundi 9 juillet 2018 - 13:12:02

Identifiants

Collections

PASTEUR | UNIV-PARIS5 | UNIV-FCOMTE | UMR645 | USPC

Citation

Sylvain Cardinaud, Romain Bouziat, Pierre-Simon Rohrlich, Sophie Tourdot, Laurence Weiss, et al.. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.. AIDS, Lippincott, Williams & Wilkins, 2009, 23 (15), pp.1945-54. 〈10.1097/QAD.0b013e32832fae88〉. 〈inserm-00484766〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

409

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD